The Evinova Origin Story

A call to action

Our story began in 2018.

‍

The cost of drug development was increasing, but industry productivity was not. We started looking into the challenges facing clinical development, and quickly realized the industry’s problems were much bigger than any available off-the-shelf product was capable of solving.

‍

We could see huge potential for digital technologies to transform clinical development but knew that bringing this vision to life would require more than a single technology, or even multiple pilots.

‍

We needed end-to-end digital solutions that were built for life sciences, by life sciences.

‍

These digital solutions would need to solve three major challenges:

‍

‍

Inefficiency

The way clinical trials were being run hadn’t substantively changed in fifty years. Many industries had achieved great success with digital transformation, but clinical development was lagging behind.

‍

90% of trial data was still being collected manually at hospital sites. High levels of patient burden meant that less than 3% of eligible patients were joining clinical studies.

‍

Over 18 months were lost due to delays in study design, planning, and recruitment, impeding the speed of getting important medicines to patients. And large pharma companies were losing billions in opportunities for future revenue without a solution for these issues.

‍

‍

Poor human experience

Clinical trials weren’t focused on improving human experience, and were a painful experience for patients, sites, and data management teams alike.

‍

Patients felt lonely and isolated, and lacked understanding of how their participation in clinical trials was contributing to advanced scientific understanding of a disease or a new breakthrough therapy.

‍

Systems and processes developed to meet regulatory requirements had been created by teams without first-hand experience of using them, and new digital solutions often overlooked challenges faced by sponsors and Contract Research Organizations (CROs).

‍

‍

Fragmentation

There was no single, overarching digital solution capable of solving all of these problems.

‍

Initial steps had been taken: new products were relieving patient burden by allowing them to provide data from home; and other companies were acquiring new products through strategic acquisitions, bringing multiple solutions under the same supplier. But in each case, a key challenge remained: lack of integration.

‍

Conducting a study often required working with numerous vendors, each with different devices, apps, processes, and systems - something we experienced first-hand.

‍

This fragmentation was cumbersome for clinical teams, and overwhelming for patients, leading to high drop-out rates and further delaying clinical development.

‍

‍

‍

‍

Solving the industry’s biggest challenges

Clinical development faces many challenges. We already know:

‍

‍

‍

‍

We strongly believe that digital solutions are capable of transforming

‍

• the way people are diagnosed
• how treatments are developed
• how patients are treated
• how patients and caregivers understand their contribution to science

‍

But life sciences needed digital solutions to do more. An overhaul of traditional approaches to clinical trials was long overdue.

‍

‍

‍

‍

We decided to do something about it

In 2018, we began researching the needs of therapeutic areas on a global scale.

‍

Across 9 countries, we engaged patients, caregivers, sites, and healthcare providers to understand the most pressing issues facing clinical development.

‍

‍

We discovered

Our findings, published in the Nature publication

When used to improve human experience, digital solutions can lead to improved patient experience and outcomes.

‍

‍

‍

‍

Leading the way

In 2023, we launched Evinova to bring our digital healthtech solutions to the healthcare community.

‍

Our multidisciplinary team of more than 300 employees are spread across nine countries, and combine deep industry experience, sector-specific scientific knowledge, and digital expertise.

‍

‍

Looking ahead

‍

Our purpose is to empower life sciences to accelerate better health outcomes. In our first year, we’ve already reached some significant milestones. We are proud to have progressed 10 contracts with large pharma, clinical research organisations and biotechs and made our solutions available for the industry.

‍

We’ve established strategic collaborations with leading CROs like Parexel and Fortrea. Our products are being used to optimize clinical trial design and delivery in 40+ countries, and our team is supporting hundreds of studies.

‍

Prior to company formation, we topped the 2023 IDEA Pharma Digital Innovation Index, and were recognised at the 2023 Clinical Trials Arena Excellence Awards, winning in the Business Expansion category.

‍

But we know innovation is hard work, and we’re committed to deliver. The key to making digital solutions with impact is in delivery and scaling, which both require resilience.

‍

Especially as the digital landscape continues to change.

‍

Our teams are dedicated to developing and expanding the capabilities of our Unified Trial Solution and Drug Development Suite.

‍

We’re also excited to be collaborating with Accenture and Amazon Web Services in order to accelerate industry adoption of our solutions.

‍

We’re on a mission to empower the sector with digital solutions and to accelerate better health outcomes. If you share our passion, we would love to collaborate and make those ambitions a reality.